Bruker announces successful installation of World’s First compact 900 MHz actively refrigerated magnet for NMR spectroscopy at UCSD

Bruker today announced the successful installation of an Ascend™ Aeon 900 magnet, the world’s first compact, single-story NMR magnet with active refrigeration at the University of California, San Diego (UCSD) in La Jolla, CA.  The Aeon technology integrates advanced refrigeration technology into the magnet design, thus providing independence from the periodic cryogen refills customary with traditional NMR magnets.  Combining the Aeon technology with Bruker’s established 900 MHz UltraStabilized™ magnet technology delivers unmatched convenience for customers.

The Ascend Aeon 900 is a liquid nitrogen-free, superconducting magnet system with helium reliquefaction technology.  It enables long-term, carefree operation without user maintenance and with essentially helium-consumption-free operation.  Whereas traditional 900 MHz magnets require two-story laboratories, the new compact Ascend Aeon 900 magnet can be placed in single-story labs due to advancements in superconductors, jointing technologies and novel magnet designs.  Researchers with restricted laboratory space can now benefit from the sensitivity and dispersion of ultra-high field solid-state NMR with this first ever single-story 900 MHz magnet.  The reduced height and minimum stray magnetic fields of this new magnet maximize siting flexibility and reduce site preparation costs.

Ascend Aeon 900 NMR magnet
Ascend Aeon 900 NMR magnet

With the introduction of new Aeon technology for 400-700 MHz NMR magnets earlier this year, and now the new Ascend Aeon 900, Bruker continues to respond to concerns regarding potential Helium shortages and increasing Helium costs.  Ascend Aeon magnets achieve this by combining the latest active-shielding technology with Bruker’s advanced, proprietary refrigeration designs, featuring integrated low-vibration cryo-coolers for reliable long-term operation.

The University of California, San Diego purchased the Ascend Aeon 900 magnet together with Bruker’s AVANCE™ III HD NMR spectrometer to provide state-of-the-art NMR capabilities at the UCSD Biomedical Technology Research Center (BTRC) for Molecular Imaging of Proteins.  The new instrument will be used for the development and application of high-resolution solid-state NMR spectroscopy to proteins in biological supramolecular assemblies, especially membranes.  The Collaborative and Service activities of the BTRC ensure that the instrument is available to the UCSD biomedical research community.

Dr. Stanley Opella, Distinguished Professor of Chemistry and Biochemistry at USCD, commented: “I am impressed by Bruker’s ability to realize the fast further development of ultra-high field magnet technology.  All of us at the Center are delighted by the fact that we now have a fully operational, robust, compact, and unique 900 MHz magnet available for our own NMR research and that of our users.  Bruker’s extraordinary customer support ensured ‘on time’ delivery and very rapid, problem-free installation of a technology currently at the leading edge of magnet development that is already showing highly reliable performance on very demanding high-power and fast spinning NMR experiments.  This novel spectrometer provides a reassuring boost for achieving our own scientific research goals in new areas of solid-state NMR spectroscopy and structural biology.”

About Bruker Corporation

Bruker Corporation (NASDAQ: BRKR) is a leading provider of high performance scientific instruments and solutions for molecular and materials research, as well as for diagnostics, industrial and applied analysis.

For more information: www.bruker.com

For more information on Ascend Aeon: www.bruker.com/Aeon

Media Contact:
Dr. Thorsten Thiel
Bruker Director of Marketing Communications
T: +49 (721) 5161 – 6500

E: [email protected]

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy